Factors Associated with Immune Checkpoint Inhibitor-Related Myocarditis

Yoshito Zamami; Takahiro Niimura; Naoto Okada; Toshihiro Koyama; Keijo Fukushima; Yuki Izawa-Ishizawa; Keisuke Ishizawa

doi:10.1001/jamaoncol.2019.3113

Factors Associated with Immune Checkpoint Inhibitor-Related Myocarditis

Yoshito Zamami, Takahiro Niimura, Naoto Okada, Toshihiro Koyama, Keijo Fukushima, Yuki Izawa-Ishizawa, Keisuke Ishizawa

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	1635-1637
Number of pages	3
Journal	JAMA Oncology
Volume	5
Issue number	11
DOIs	https://doi.org/10.1001/jamaoncol.2019.3113
Publication status	Published - Nov 2019

ASJC Scopus subject areas

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1001/jamaoncol.2019.3113

Cite this

@article{4148f3bbc2754f9ca40bbbcd68c74927,

title = "Factors Associated with Immune Checkpoint Inhibitor-Related Myocarditis",

author = "Yoshito Zamami and Takahiro Niimura and Naoto Okada and Toshihiro Koyama and Keijo Fukushima and Yuki Izawa-Ishizawa and Keisuke Ishizawa",

note = "Funding Information: This research was partially supported by a Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research [BINDS] from AMED under grant No. JP18am0101085). This research was supported by the Japan Research Foundation for Clinical Pharmacology Grant (No. 2018A10) and the Japan Society for the Promotion of Science (JSPS) KAKENHI (No. 18K06785). The authors also received support of crowdfunding launched by Otsucle (Organization for People With Universities) for development of a preventive drug against the adverse effects of anticancer agents (Tokushima, Japan).",

year = "2019",

month = nov,

doi = "10.1001/jamaoncol.2019.3113",

language = "English",

volume = "5",

pages = "1635--1637",

journal = "JAMA oncology",

issn = "2374-2437",

publisher = "American Medical Association",

number = "11",

}

TY - JOUR

T1 - Factors Associated with Immune Checkpoint Inhibitor-Related Myocarditis

AU - Zamami, Yoshito

AU - Niimura, Takahiro

AU - Okada, Naoto

AU - Koyama, Toshihiro

AU - Fukushima, Keijo

AU - Izawa-Ishizawa, Yuki

AU - Ishizawa, Keisuke

N1 - Funding Information: This research was partially supported by a Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research [BINDS] from AMED under grant No. JP18am0101085). This research was supported by the Japan Research Foundation for Clinical Pharmacology Grant (No. 2018A10) and the Japan Society for the Promotion of Science (JSPS) KAKENHI (No. 18K06785). The authors also received support of crowdfunding launched by Otsucle (Organization for People With Universities) for development of a preventive drug against the adverse effects of anticancer agents (Tokushima, Japan).

PY - 2019/11

Y1 - 2019/11

UR - http://www.scopus.com/inward/record.url?scp=85071379539&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071379539&partnerID=8YFLogxK

U2 - 10.1001/jamaoncol.2019.3113

DO - 10.1001/jamaoncol.2019.3113

M3 - Letter

C2 - 31436802

AN - SCOPUS:85071379539

SN - 2374-2437

VL - 5

SP - 1635

EP - 1637

JO - JAMA oncology

JF - JAMA oncology

IS - 11

ER -

Factors Associated with Immune Checkpoint Inhibitor-Related Myocarditis

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this